Skip to main content
SpringerLink
Log in

Glomerular Disease Associated with Rheumatic Diseases Other than SLE

  • Living reference work entry
  • First Online:
Glomerulonephritis

  • 272 Accesses

Abstract

Nephrologists will frequently be consulted to evaluate kidney injury in patients with rheumatic diseases. In the majority of patients, kidney injury will be a side effect of the antirheumatic drugs. Also, it is now well recognized that chronic kidney disease (CKD) is more frequently observed in patients with rheumatic diseases.

Glomerular diseases are rare, with the exception of glomerular thrombosis in patients with scleroderma (scleroderma renal crisis). In most patients with rheumatic diseases and evidence of glomerular injury, a kidney biopsy is needed to establish a diagnosis and guide therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Similar content being viewed by others

References

  • Anders HJ, Vielhauer V (2011) Renal co-morbidity in patients with rheumatic diseases. Arthritis Res Ther 13(3):222

    Article  PubMed  PubMed Central  Google Scholar 

  • Arad U, Balbir-Gurman A, Doenyas-Barak K, Amit-Vazina M, Caspi D, Elkayam O (2011) Anti-neutrophil antibody associated vasculitis in systemic sclerosis. Semin Arthritis Rheum 41:223–229

    Article  CAS  PubMed  Google Scholar 

  • DeMarco PJ, Weisman MH, Seibold JR, Furst DE, Wong WK, Hurwitz EL, Mayes M, White B, Wigley F, Barr W, Moreland L, Medsger TA Jr, Steen V, Martin RW, Collier D, Weinstein A, Lally E, Varga J, Weiner SR, Andrews B, Abeles M, Clements PJ (2002) Predictors and outcomes of scleroderma renal crisis: the high-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis trial. Arthritis Rheum 46(11):2983–2989

    Article  CAS  PubMed  Google Scholar 

  • Denton CP, Hughes M, Gak N, Vila J, Buch MH, Chakravarty K, Fligelstone K, Gompels LL, Griffiths B, Herrick AL, Pang J, Parker L, Redmond A, van Laar J, Warburton L, Ong VH, BSR and BHPR Standards, Guidelines and Audit Working Group (2016) BSR and BHPR guideline for the treatment of systemic sclerosis. Rheumatology 55(10):1906–1910

    Article  PubMed  Google Scholar 

  • Derrett-Smith EC, Nihtyanova SI, Harvey J, Salama AD, Denton CP (2013) Revisiting ANCA-associated vasculitis in systemic sclerosis: clinical, serological and immunogenetic factors. Rheumatology 52(10):1824–1831

    Article  CAS  PubMed  Google Scholar 

  • Dumitrescu G, Dahan K, Treton X, Corcos O, Bouhnik Y, Stefanescu C (2015) Nephrotic syndrome after infliximab treatment in a patient with ulcerative colitis. J Gastrointestin Liver Dis 24(2):249–251

    PubMed  Google Scholar 

  • Goules AV, Tatouli IP, Moutsopoulos HM, Tzioufas AG (2013) Clinically significant renal involvement in primary Sjögren’s syndrome: clinical presentation and outcome. Arthritis Rheum 65(11):2945–2953

    Article  PubMed  Google Scholar 

  • Guillevin L, Bérezné A, Seror R, Teixeira L, Pourrat J, Mahr A, Hachulla E, Agard C, Cabane J, Vanhille P, Harle JR, Deleveaux I, Mouthon L (2012) Scleroderma renal crisis: a retrospective multicentre study on 91 patients and 427 controls. Rheumatology 51(3):460–467

    Article  CAS  PubMed  Google Scholar 

  • Gunnarsson R, Hetlevik SO, Lilleby V, Molberg Ø (2016) Mixed connective tissue disease. Best Pract Res Clin Rheumatol 30(1):95–111

    Article  PubMed  Google Scholar 

  • Helfrich DJ, Banner B, Steen VD, Medsger TA Jr (1989) Normotensive renal failure in systemic sclerosis. Arthritis Rheum 32(9):1128–1134

    Article  CAS  PubMed  Google Scholar 

  • Hickson LJ, Crowson CS, Gabriel SE, McCarthy JT, Matteson EL (2014) Development of reduced kidney function in rheumatoid arthritis. Am J Kidney Dis 63(2):206–213

    Article  CAS  PubMed  Google Scholar 

  • Hudson M, Baron M, Tatibouet S, Furst DE, Khanna D, International Scleroderma Renal Crisis Study Investigators (2014) Exposure to ACE inhibitors prior to the onset of scleroderma renal crisis-results from the international scleroderma renal crisis survey. Semin Arthritis Rheum 43(5):666–672

    Article  CAS  PubMed  Google Scholar 

  • Izzedine H, Rouvier P, Deray G (2013) Endothelin receptor antagonism-based treatment for scleroderma renal crisis. Am J Kidney Dis 62(2):394–395

    Article  CAS  PubMed  Google Scholar 

  • Kaneko K, Nanki T, Hosoya T, Mizoguchi F, Miyasaka N (2010) Etanercept-induced necrotizing crescentic glomerulonephritis in two patients with rheumatoid arthritis. Mod Rheumatol 20(6):632–636

    Article  PubMed  Google Scholar 

  • Kaufman I, Schwartz D, Caspi D, Paran D (2008) Sjögren’s syndrome – not just Sicca: renal involvement in Sjögren’s syndrome. Scand J Rheumatol 37(3):213–218

    Article  CAS  PubMed  Google Scholar 

  • Kidder D, Rutherford E, Kipgen D, Fleming S, Geddes C, Stewart GA (2015) Kidney biopsy findings in primary Sjögren syndrome. Nephrol Dial Transplant 30(8):1363–1369

    Article  PubMed  Google Scholar 

  • Kitaura K, Miyagawa T, Asano K, Oouchi S, Miki T, Fujisawa T, Ishida K (2006) Mixed connective tissue disease associated with MPO-ANCA-positive polyangiitis. Intern Med 45(20):1177–1182

    Article  PubMed  Google Scholar 

  • Kitridou RC, Akmal M, Turkel SB, Ehresmann GR, Quismorio FP Jr, Massry SG (1986) Renal involvement in mixed connective tissue disease: a longitudinal clinicopathologic study. Semin Arthritis Rheum 16(2):135–145

    Article  CAS  PubMed  Google Scholar 

  • Kochi M, Kohagura K, Shiohira Y, Iseki K, Ohya Y (2016) Inflammation as a risk of developing chronic kidney disease in rheumatoid arthritis. PLoS One 11(8):e0160225

    Article  PubMed  PubMed Central  Google Scholar 

  • Koya M, Pichler R, Jefferson JA (2012) Minimal-change disease secondary to etanercept. Clin Kidney J 5(5):420–423

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Ligon CB, Hummers LK, McMahan ZH (2015) Oxalate nephropathy in systemic sclerosis: case series and review of the literature. Semin Arthritis Rheum 45(3):315–320

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Lopez-Ovejero JA, Saal SD, D’Angelo WA, Cheigh JS, Stenzel KH, Laragh JH (1979) Reversal of vascular and renal crises of scleroderma by oral angiotensin-converting-enzyme blockade. N Engl J Med 300(25):1417–1419

    Article  CAS  PubMed  Google Scholar 

  • Maripuri S, Grande JP, Osborn TG, Fervenza FC, Matteson EL, Donadio JV, Hogan MC (2009) Renal involvement in primary Sjögren’s syndrome: a clinicopathologic study. Clin J Am Soc Nephrol 4(9):1423–1431

    Article  PubMed  PubMed Central  Google Scholar 

  • Moinzadeh P, Riemekasten G, Siegert E, Fierlbeck G, Henes J, Blank N, Melchers I, Mueller-Ladner U, Frerix M, Kreuter A, Tigges C, Lahner N, Susok L, Guenther C, Zeidler G, Pfeiffer C, Worm M, Karrer S, Aberer E, Bretterklieber A, Genth E, Simon JC, Distler JH, Hein R, Schneider M, Seitz CS, Herink C, Steinbrink K, Sárdy M, Varga R, Mensing H, Mensing C, Lehmann P, Neeck G, Fiehn C, Weber M, Goebeler M, Burkhardt H, Buslau M, Ahmadi-Simab K, Himsel A, Juche A, Koetter I, Kuhn A, Sticherling M, Hellmich M, Kuhr K, Krieg T, Ehrchen J, Sunderkoetter C, Hunzelmann N (2016) German network for systemic scleroderma. Vasoactive therapy in systemic sclerosis: real-life therapeutic practice in more than 3000 patients. J Rheumatol 43(1):66–74

    Article  CAS  PubMed  Google Scholar 

  • Montanelli G, Beretta L, Santaniello A, Scorza R (2013) Effect of dihydropyridine calcium channel blockers and glucocorticoids on the prevention and development of scleroderma renal crisis in an Italian case series. Clin Exp Rheumatol 31(2 Suppl 76):135–139

    PubMed  Google Scholar 

  • Mouthon L, Bussone G, Berezné A, Noël LH, Guillevin L (2014) Scleroderma renal crisis. J Rheumatol 41(6):1040–1048

    Article  CAS  PubMed  Google Scholar 

  • Ortega-Hernandez OD, Shoenfeld Y (2012) Mixed connective tissue disease: an overview of clinical manifestations, diagnosis and treatment. Best Pract Res Clin Rheumatol 26(1):61–72

    Article  CAS  PubMed  Google Scholar 

  • Penn H, Howie AJ, Kingdon EJ, Bunn CC, Stratton RJ, Black CM, Burns A, Denton CP (2007) Scleroderma renal crisis: patient characteristics and long-term outcomes. QJM 100(8):485–494

    Article  CAS  PubMed  Google Scholar 

  • Penn H, Quillinan N, Khan K, Chakravarty K, Ong VH, Burns A, Denton CP (2013) Targeting the endothelin axis in scleroderma renal crisis: rationale and feasibility. QJM 106(9):839–848

    Article  CAS  PubMed  Google Scholar 

  • Qin B, Wang J, Yang Z, Yang M, Ma N, Huang F, Zhong R (2015) Epidemiology of primary Sjögren’s syndrome: a systematic review and meta-analysis. Ann Rheum Dis 74(11):1983–1989

    Article  CAS  PubMed  Google Scholar 

  • Quéméneur T, Mouthon L, Cacoub P, Meyer O, Michon-Pasturel U, Vanhille P, Hatron PY, Guillevin L, Hachulla E (2013) Systemic vasculitis during the course of systemic sclerosis: report of 12 cases and review of the literature. Medicine 92(1):1–9

    Article  PubMed  PubMed Central  Google Scholar 

  • Ren H, Wang WM, Chen XN, Zhang W, Pan XX, Wang XL, Lin Y, Zhang S, Chen N (2007) Renal involvement and follow-up of 130 patients with primary Sjögren’s syndrome. J Rheumatol 35(2):278–284

    PubMed  Google Scholar 

  • Sharp GC, Irvin WS, Tan EM et al (1972) Mixed connective tissue disease- an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA). Am J Med 52:158–159

    Article  Google Scholar 

  • Steen VD, Medsger TA Jr (1998) Case-control study of corticosteroids and other drugs that either precipitate or protect from the development of scleroderma renal crisis. Arthritis Rheum 41(9):1613–1619

    Article  CAS  PubMed  Google Scholar 

  • Steen VD, Costantino JP, Shapiro AP, Medsger TA Jr (1990) Outcome of renal crisis in systemic sclerosis: relation to availability of angiotensin converting enzyme (ACE) inhibitors. Ann Intern Med 113(5):352–357

    Article  CAS  PubMed  Google Scholar 

  • Stokes MB, Foster K, Markowitz GS, Ebrahimi F, Hines W, Kaufman D, Moore B, Wolde D, D’Agati VD (2005) Development of glomerulonephritis during anti-TNF-alpha therapy for rheumatoid arthritis. Nephrol Dial Transplant 20(7):1400–1406

    Article  CAS  PubMed  Google Scholar 

  • Teixeira L, Mouthon L, Mahr A, Berezné A, Agard C, Mehrenberger M, Noël LH, Trolliet P, Frances C, Cabane J, Guillevin L, Group Français de Recherche sur le Sclérodermie (GFRS) (2008) Mortality and risk factors of scleroderma renal crisis: a French retrospective study of 50 patients. Ann Rheum Dis 67(1):110–116

    Article  CAS  PubMed  Google Scholar 

  • Thomas CP, Nester CM, Phan AC, Sharma M, Steele AL, Lenert PS (2015) Eculizumab for rescue of thrombotic microangiopathy in PM-Scl antibody-positive autoimmune overlap syndrome. Clin Kidney J 8(6):698–701

    Article  PubMed  PubMed Central  Google Scholar 

  • Traub YM, Shapiro AP, Rodnan GP, Medsger TA, McDonald RH Jr, Steen VD, Osial TA Jr, Tolchin SF (1983) Hypertension and renal failure (scleroderma renal crisis) in progressive systemic sclerosis. Review of a 25-year experience with 68 cases. Medicine 62(6):335–352

    Article  CAS  PubMed  Google Scholar 

  • Vinicki JP, Pellet SC, De Rosa G, Dubinsky D, Laborde HA, Marini A, Nasswetter G (2015) Analysis of 65 renal biopsies from patients with rheumatoid arthritis (1976–2015): change in treatment strategies decreased frequency and modified histopathological findings. J Clin Rheumatol 21(7):335–340

    Article  PubMed  Google Scholar 

  • Walker JG, Ahern MJ, Smith MD, Coleman M, Pile K, Rischmueller M, Cleland L, Roberts-Thomson PJ (2003) Scleroderma renal crisis: poor outcome despite aggressive antihypertensive treatment. Intern Med J 33(5–6):216–220

    Article  CAS  PubMed  Google Scholar 

  • Walker UA, Tyndall A, Czirják L, Denton C, Farge-Bancel D, Kowal-Bielecka O, Müller-Ladner U, Bocelli-Tyndall C, Matucci-Cerinic M (2007) Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR scleroderma trials and research group database. Ann Rheum Dis 66(6):754–763

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine, Hospital Gelderse Vallei, Ede, The Netherlands

    Julia M Hofstra

  2. Department of Nephrology, Radboud University Medical Center, Nijmegen, The Netherlands

    Jack FM Wetzels

Authors
  1. Julia M Hofstra
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jack FM Wetzels
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jack FM Wetzels .

Editor information

Editors and Affiliations

  1. Department of Pediatrics, NYU Langone Medical Center, New York, New York, USA

    Howard Trachtman

  2. Hospital of the Univ. of Pennsylvania, Philadelphia, Pennsylvania, USA

    Jonathan J. Hogan

  3. Cleveland Clinic, Cleveland, Ohio, USA

    Leal Herlitz

  4. Nephrology, University of Illinois at Chicago College of Medicine, Chicago, Illinois, USA

    Edgar V. Lerma

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing AG

About this entry

Cite this entry

Hofstra, J.M., Wetzels, J.F. (2017). Glomerular Disease Associated with Rheumatic Diseases Other than SLE. In: Trachtman, H., Hogan, J., Herlitz, L., Lerma, E. (eds) Glomerulonephritis. Springer, Cham. https://doi.org/10.1007/978-3-319-27334-1_47-1

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-27334-1_47-1

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-27334-1

  • Online ISBN: 978-3-319-27334-1

  • eBook Packages: Springer Reference MedicineReference Module Medicine

Publish with us

Policies and ethics

Search

Navigation